Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Covid-19 - Mobile Vaccination Teams Deployed to Weekly Markets, Inland Regions

12/02/2021 | 07:06am EST

The Health Ministry began Tuesday deploying mobile health teams to weekly markets and inland regions to deliver COVID-19 vaccines, said Adviser to the Health Minister Ines Gmati.

Other medical and paramdical teams headed Wednesday, along with the Tunisian Red Crescent, to Sidi Bouzid and Tataouine.

Gmati said vaccination campaigns are organised by local health directorates, in collaboration with healthcare and basic healthcare centres. They are geared towards the over-18s who did not receive the first dose or are not double jabbed.

The vaccines used are Pfizer and Johnson & Johnson.

Copyright Tunis Afrique Presse. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON -0.55% 167.84 Delayed Quote.-1.35%
PFIZER, INC. -1.06% 54.95 Delayed Quote.-6.94%
All news about PFIZER, INC.
01/15GSK rejects $68b Unilever bid for consumer healthcare unit
AQ
01/15Factbox-GSK's consumer health business
RE
01/15GSK rejects 50-billion-pound Unilever offer for consumer assets
RE
01/14U.S. FDA approves drugs from AbbVie, Pfizer to treat eczema
RE
01/14U.S. FDA approves Pfizer's drug to treat eczema
RE
01/14FDA Approves Pfizer's CIBNOQ For Adults With Moderate-to-Severe Atopic Dermatitis
MT
01/14U.S. FDA Approves Pfizer's CIBINQO« (abrocitinib) for Adults with Moderate-to-Severe At..
BU
01/14U.S. FDA Approves Pfizer’s CIBINQO« (abrocitinib) for Adults with Moderate-to-Seve..
CI
01/14Brazil starts vaccinating children after weeks of delay
AQ
01/14FDA approves expanded use of AbbVie's arthritis drug to treat eczema
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 916 M - -
Net income 2021 22 210 M - -
Net Debt 2021 27 661 M - -
P/E ratio 2021 14,4x
Yield 2021 2,88%
Capitalization 308 B 308 B -
EV / Sales 2021 4,10x
EV / Sales 2022 3,31x
Nbr of Employees 78 500
Free-Float -
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 54,95 $
Average target price 57,10 $
Spread / Average Target 3,90%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-6.94%308 427
JOHNSON & JOHNSON-1.35%441 855
ROCHE HOLDING AG-3.72%323 901
ABBVIE INC.0.35%240 202
ELI LILLY AND COMPANY-11.62%221 317
NOVO NORDISK A/S-15.01%218 444